The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib in treatment-naïve chronic lymphocytic leukemia: Mature results from phase II study demonstrating durable remissions and long-term tolerability.
 
John C. Byrd
No Relationships to Disclose
 
Jennifer Ann Woyach
Consulting or Advisory Role - ArQule; AstraZeneca; Janssen; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; Loxo; MorphoSys; Verastem
 
Richard R. Furman
Honoraria - Genentech/Roche; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; Beigene; Genentech/Roche; Incyte; Janssen Biotech; Loxo; OncoTracker; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Acerta Pharma; TG Therapeutics
Expert Testimony - Abbvie; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology; TG Therapeutics
Other Relationship - Abbvie; Incyte; Janssen Biotech
 
Peter Martin
Consulting or Advisory Role - Bayer; BeiGene; Celgene; Cellectar; I-Mab; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; MorphoSys; Sandoz; TeneoBio
Research Funding - Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Janssen
 
Susan Mary O'Brien
Employment - University of California, Irvine
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Eisai; Gilead Sciences; GlaxoSmithKline; Janssen; Loxo; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Research Funding - Acerta Pharma (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron
 
Jennifer R. Brown
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BeiGene; Catapult Therapeutics; Dynamo Therapeutics; Juno/Celgene; Kite, a Gilead company; MEI Pharma; Novartis; Octapharm; Pfizer; Sunesis Pharmaceuticals; TG Therapeutics
Research Funding - Gilead Sciences; Loxo; Sun Pharma; Verastem
Other Relationship - Invectys; MorphoSys
 
Deborah Marie Stephens
Honoraria - Genentech
Consulting or Advisory Role - Pharmacyclics/Janssen
Research Funding - Acerta Pharma; Gilead Sciences; Juno Therapeutics; Karyopharm Therapeutics; Verastem
 
Jacqueline Claudia Barrientos
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Bayer; Genentech; Gilead Sciences; Pharmacyclics; Sandoz
Research Funding - AstraZeneca (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - Janssen
 
Stephen Devereux
No Relationships to Disclose
 
Peter Hillmen
Honoraria - Abbvie; Janssen; Roche
Research Funding - Gilead Sciences (Inst); Janssen (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen
 
John M. Pagel
Consulting or Advisory Role - Actinium Pharmaceuticals; AstraZeneca; Gilead Sciences; Pharmacyclics
 
Ahmed M. Hamdy
Employment - Acerta Pharma
Leadership - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Patents, Royalties, Other Intellectual Property - Acerta Pharma
Travel, Accommodations, Expenses - Acerta Pharma
Other Relationship - Acerta Pharma
(OPTIONAL) Uncompensated Relationships - Acerta Pharma
 
Raquel Izumi
Employment - Acerta Pharma
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - Acerta Pharma
 
Priti Patel
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Min Hui Wang
Employment - Acerta Pharma
Stock and Other Ownership Interests - AstraZeneca
 
Nitin Jain
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Janssen; Pharmacyclics
Research Funding - Bristol-Myers Squibb (Inst); Infinity Pharmaceuticals (Inst); Pharmacyclics (Inst)
 
William G. Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Cyclacel; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Loxo; miRagen; Oncternal Therapeutics, Inc; Pharmacyclics; Sunesis Pharmaceuticals; Xencor